FDA authorizes new Covid-19 monoclonal antibody that works against Omicron variant

4 years ago 30

The US Food and Drug Administration has authorized a new monoclonal antibody treatment that seems to work against the Omicron variant of the virus that causes Covid-19.

1. Homepage
2. National News
3. FDA authorizes new Covid-19 monoclonal antibody that works against Omicron variant